Recruiting
Apatinib With CDK4/6 Inhibitor and Endocrine Therapy in HR+/ HER2- Advanced Breast Cancer
NCT05759572
- Conditions
- Breast Cancer Metastatic
- Locations
-
- Breast cancer institute of Fudan University Cancer Hospital Shanghai, Shanghai Municipality, China